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ABSTRACT
THE IMPACT OF PAROXYSMAL SYMPATHETIC HYPERACTIVITY
FOLLOWING TRAUMATIC BRAIN INJURY ON INTENSIVE CARE UNIT
LENGTH OF STAY AND DISCHARGE DISPOSITION
Kimberly S Meyer
October 25, 2016
Paroxysmal Sympathetic Hyperactivity (PSH) is a complication
affecting a subset of patients with severe traumatic brain injury (TBI). It is
associated with increased morbidity, longer lengths of stay, and delayed
recovery (Perkes, Baguley, Nott, & Menon, 2010). The most prevalent
signs and symptoms of PSH include unprovoked tachycardia, tachypnea,
hypertension, dystonia, and diaphoresis (Lemke, 2007). If untreated, PSH
can lead to impaired cerebral blood flow, sub-endocardial damage,
dehydration, malnourishment, and contractures (Lemke, 2007).
The purpose of this study was to determine the incidence of PSH in
an American Level 1 trauma center, examine the differences between
patients with severe TBI and those who develop PSH in terms of intensive
care unit length of stay (ICULOS) and discharge disposition, and identify
predictors of ICULOS in the patients with PSH. Data were abstracted from
medical records (N=196) of patients with TBI.
v

Results from this retrospective study indicate that there was no
difference in intensive unit (ICU) length of stay in TBI patients with PSH
compared to those without PSH. However, there was a significant
difference in discharge disposition, so that patients without PSH were
more likely to be discharged to a home or acute rehabilitation setting while
those with PSH were more likely to be discharged to sub-acute
rehabilitation or other high level medical care. Evaluation of physiologic
parameters known to be abnormal in patients with PSH indicated that in
this sample, only heart rate was a significant predictor of the development
of PSH. This suggests that is it reasonable to screen younger patients
who exhibit signs of sympathetic hyperactivity after TBI for PSH.
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CHAPTER I
INTRODUCTION

Traumatic brain injury (TBI) affects over 1 million Americans annually
(Centers for Disease Control and Prevention (CDC), 2010). Although only a small
percentage of TBI is categorized as severe, this subgroup is at risk for prolonged
hospital stays, persistent disability, and increased lifetime healthcare utilization
resulting in significant burden to the healthcare system (CDC, 2010; Perkes et
al., 2010; Whitmore et al., 2012). Acute care length of stay following
uncomplicated severe TBI averages 18 days with hospital charges upward of
$95,000 per stay (Frankel et al., 2006). Up to one third of all severe TBI survivors
may develop paroxysmal sympathetic hyperactivity (PSH), a condition that
further complicates TBI recovery and lessens the likelihood for functional
recovery (Hinson & Sheth, 2012; Whyte et al., 2013). International literature
suggests that those patients with PSH are at risk for prolonged lengths of stay in
the intensive care unit and increased morbidity (Fernandez-Ortega et al., 2012).
Clinical experience suggests that delayed mobilization, longer intensive
care unit length of stay (ICULOS), delayed coma emergence, and failure to
qualify for acute brain injury rehabilitation are related to autonomic instability
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(Figure 1). Identification of predictors most influential in ICULOS may lead to
earlier intervention and control of autonomic discharges. In turn, this might
facilitate the earlier use of pharmacologic neuro-stimulation, rehabilitation and
expedite discharge to high level brain injury recovery programs (Wheaton,
Mathias, & Vink, 2009; Whyte et al., 2013) as specialized care by neurotrauma
specialists in acute care and rehabilitation is known to improve hospital outcome
and the likelihood of community re-integration following TBI (Haas et al., 2009;
Kramer & Zygun, 2014; Whyte et al., 2013).
The purpose of this dissertation was threefold. First, the study aimed to
determine the incidence of PSH in an American sample of severe TBI patients
treated at a level 1 trauma center. Secondly, it sought to examine the effect of
PSH on short-term outcome as measured by discharge destination. Lastly, the
study explored the predictors that most influence ICULOS in patients with PSH.
The first manuscript is a review of literature. It indicates that PSH is a
poorly understood condition and as a result, recognition and treatment of the
symptom complexes is often delayed (Fernandez-Ortega et al., 2006). Brief, but
frequent episodes of hemodynamic instability and physiologic distress
manifested by shaking and profuse diaphoresis are the hallmarks of this
condition (Lemke, 2007). Imaging studies in patients experiencing PSH often
reveal evidence of diffuse axonal injury (Baguley, 2004; Baguley, 1999; Boeve,
Wijdicks, Benarroch, & Schmidt 1998a; Bower, 2010). Coma emergence and
weaning from high dose opiates and sedatives are precursors frequently
associated with the onset of signs and symptoms associated with PSH.
2

The second manuscript provides a concept analysis, comparing the
sympathetic hyperactivity of PSH to the sympathetic surges seen in contrary
cases of cerebral herniation syndrome. It identifies surrogate terms for PSH that
were frequently used prior to the development of a standardized definition and
nomenclature. Nursing surveillance was identified as a critical factor in the
identification of PSH related symptoms.
The final manuscript presents findings from a retrospective study of 196
patients who had sustained a severe traumatic brain injury. The subjects were
dichotomized into groups: those with PSH and those with normal TBI recovery
trajectory. Although there was no difference in ICULOS between the two groups,
those with PSH were less likely to discharge to acute rehabilitation than their
counterparts without PSH. Heart rates at multiple time points were most
predictive of the condition of PSH.
Results from this dissertation suggest that patients with coma after TBI
who develop unprovoked periods of tachycardia should be further screened for
PSH. Other findings indicate that those with higher discharge Glasgow Coma
Scores, as seen in the TBI group, were associated with discharge to high-level
brain injury rehabilitation.
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Figure 1
Theoretical Effect of PSH on TBI Recovery
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The expected recovery course of traumatic brain injury (TBI) follows the path from acute care to rehabilitation and
community re-entry. The effects of paroxysmal sympathetic hyperactivity (PSH) may alter the recovery trajectory and
delay or prohibit maximal recovery

CHAPTER II
UNDERSTANDING PAROXYSMAL SYMPATHETIC HYPERACTIVITY
AFTER TRAUMATIC BRAIN INJURY (Meyer, 2014: Appendix 1)

Overview
Traumatic brain injury (TBI) affects 1.4 million Americans annually (CDC,
2010). Although only a small percentage of TBI is categorized as severe or
comatose state, this subgroup of patients is at risk for prolonged hospital stays,
persistent disability, and increased lifetime healthcare utilization (CDC, 2010).
This sub-population of patients with TBI accounts for up to ninety percent of all
TBI-related costs (CDC, 2010). Paroxysmal sympathetic hyperactivity (PSH) has
been reported in up to 33% of patients with severe TBI (Hinson & Sheth, 2012).
PSH has been discussed in the literature under a variety of terms. Early in
the recognition of this phenomenon, the term diencephalic seizure was used
(Penfield, 1929). However, later investigations failed to demonstrate epileptiform
discharges on electroenecephalography so this term has seen a decrease in
usage (Boeve et al., 1998a; Lemke, 2007). PSH later became known as
dysautonomia, autonomic storming, sympathetic storming, and autonomic
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dysreflexia or hyper-reflexia (Baguley et al., 1999). The International Brain Injury
Association has recently convened a consensus workgroup to clarify the
nomenclature and diagnostic criteria for this entity. The proposed term from this
consensus group is paroxysmal sympathetic hyperactivity (Baguley et al., 2014).
To date, the vast majority of literature pertaining to PSH is found in the medical
literature with attention paid to hypothesis of cause and pharmacologic
management. With few exceptions, studies are limited to retrospective reviews,
case studies, or small case series, thereby limiting their generalizability.
PSH is a poorly understood phenomenon with varied symptomatology. As
a result, identification of the condition is often delayed (Hendricks, Heeren, &
Vos, 2010). Diagnosis is often one of exclusion, where other conditions with
similar symptoms, such as infection or withdrawal, are ruled out. Brief, but
frequent episodes of hemodynamic instability and physiologic distress are the
hallmarks of this condition (Baguley et al., 2014; Lemke, 2007). Imaging studies
in patients experiencing sympathetic storming often reveal evidence of diffuse
axonal injury (Baguley et al., 2004; Boeve et al., 1998a). Coma emergence and
weaning from high dose opiates and sedatives are precursors that are frequently
associated with sign or symptom exhibition. Baguley et al., suggest that PSH is
present if the following symptoms occur without other identifiable causes:
hyperthermia, tachycardia, tachypnea, dystonia, hypertension, posturing and
diaphoresis (Baguley et al., 1999; Lemke, 2007). Identification of these signs or
symptoms often results in additional diagnostic work-up and increased
medication requirements.
6

Pathophysiology
PSH is thought to occur in stages. The first stage is often asymptomatic
due to the heavy sedation and paralytics required for the acute management of
intracranial hypertension and other trauma-related injuries. The second stage is
characterized by the onset of symptom clusters and the third stage, by a decline
in posturing and dystonia (Baguley et al, 1999). Baguley, Nott et al., (2009) and
Baguley, Heriseanu et al., (2009) demonstrated that changes in heart rate
variability associated with nociceptive stimuli accompany the onset of
sympathetic storming. Retrospective reviews indicate that those with diffuse
axonal injury on imaging studies are at highest risk for developing sympathetic
storming (Baguley et al., 1999; Hendricks et al., 2010). Symptoms are thought to
persist for months to years, with one study revealing a mean duration of 5 years
post-injury (Baguley et al., 2009).
Various dissociation theories provide the theoretical framework for PSH.
These include those of structural disconnection where lesions in the
mesencephalon cause disruptions in relay from the medulla/hypothalamus and
the more widely accepted excitatory: inhibitory ratio (EIR) model where
dysfunction of the diencephalic-brainstem inhibitory center that normally controls
afferent stimulus processing in the spinal cord occurs (Baguley, 2008b;
Fernandez-Ortega et al., 2006; Lemke, 2007). Autonomic dysfunction is thought
to result from functional disconnections related to traumatic damage involving the
deep structures of the brain (Baguley, Heriseanu, Cameron et al., 2008). This is
complicated by a relative reduction in functional dopaminergic activity (Baguley,
7

Heriseanu, Cameron et al., 2008). As a result, there is unopposed adrenergic
outflow with increased levels of circulating catecholamines (Baguley, Heriseanu,
Cameron et al., 2008). Within this framework, there is an increase in the
excitatory influences without a compensatory increase in inhibitory function, thus
creating a tendency to develop an over-reaction to normally non-noxious stimuli
(Baguley, Heriseanu, Nott et al., 2009; Baguley, Nott, Slewa-Younan et al.,
2009). Multisystem organ dysfunction can follow if the condition is untreated.
Treatment
There is no accepted treatment algorithm for the management of PSH.
Treatment is aimed at mitigating signs and symptoms to decrease associated
adverse events such as cardiac hypertrophy, dehydration, muscle wasting,
contractures, and delayed recovery which contribute to increased morbidity
(Table 1). Multiple medications are often required to successfully control the
multiple symptoms. Dopaminergic agents, specifically bromocriptine, have been
shown to decrease body temperature and sweating (Bullard, 1987; Rossitch &
Bullard, 1988; Russo & O’Flaherty, 2000). Alpha-agonists such as clonidine act
to decrease heart rate and blood pressure (Payen, Quentin, Plaisance, Chiron, &
Lhoste, 1990; Russo & O’Flaherty, 2000; Patel et al., 2012). GABA agonists are
also useful in some cases. Baclofen can be given enterally or intrathecally.
Intrathecal baclofen significantly reduces symptoms at substantially lower doses
and subsequently, less toxicity (Cuny, Richer, & Castel, 2001; Becker, Benes,
Sure, Hellwig, & Bertanlanffy, 2000). Gabapentin is thought to act on the dorsal
horn of the spinal cord and in one small study, reduced the need for concomitant
8

medications (Baguley, Slewa-Younan, et al., 2007). Opiates and non-selective
beta-blockers have also been used (Baguley et al., 2004; Bullard, 1987).
In cases of medication failure, a case series of six patients demonstrated
that hyperbaric oxygen (HBOT) controlled autonomic discharges and posturing in
the sub-acute TBI phase (Lv et al., 2011). However, this treatment modality is of
limited utility as there are an inadequate number of facilities with HBOT
capabilities and the duration of therapy is prohibitive. Large experimental studies
to validate the findings in these smaller studies are challenging due to difficulties
in early identification of PSH and the relatively small number of qualifying
patients.
Implications
Early identification and treatment of PSH is critical to facilitate recovery
from traumatic brain injury and avoid permanent organ dysfunction. Expensive
diagnostic testing is rarely warranted. Instead, the observational and analytical
skills employed by most ICU nurses are more useful in recognizing PSH. In
addition to communication of findings in order to facilitate diagnosis and
treatment, nursing surveillance also affords the opportunity to identify and
therefore potentially mitigate triggers. A final contribution of nursing involves
family and caregiver teaching. In this role, the nurse explains the concept of
PSH, along with its causes and treatment, thereby aiding the family member to
better cope with the paroxysms that can be very frightening or chaotic to watch.
Early initiation of symptom specific therapy, although beyond the scope of
this paper, is thought to decrease complication rates and ICU length of stay and
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to facilitate recovery (Hinson & Sheth, 2012). Understanding both the cause and
complexity of these storming (PSH) events will lead to appropriate diagnosis and
improved therapeutic interventions.
Conclusion
PSH should be considered when patients emerging from coma exhibit
multiple, concurrent symptoms of sympathetic over-activity: hyperthermia,
posturing, dystonia, tachycardia, tachypnea, diaphoresis, or hypertension.
Nurses play a pivotal role in identifying the condition of PSH, observing and
mitigating the triggers which precipitate the event, communicating patient needs
to the interdisciplinary team and finally, educating the family/caregivers. Ongoing
research should include efforts to develop scales to document the frequency and
severity of these paroxysmal episodes and treatment algorithms to guide the
clinician in the management of PSH.
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Table 1
Multi System Dysfunction Associated with Sympathetic Storming/Paroxysmal
Sympathetic Hyperactivity (PSH).
Organ System

Sign/Symptom

Cardiovascular

● Tachycardia
● Increased contractility
● Increased cardiac output

Pulmonary

● Tachypnea
● Bronchial dilation

Eyes

● Pupillary dilation

Gastrointestinal

● Decreased GI motility
● Increased tube feed residual
● Ileus

Musculoskeletal

●
●
●
●

Adrenal

● Increased release of epinephrine
● Increased release of
norepinephrine

11

Dystonia
Posturing
Contractures
Spasticity

CHAPTER III
A CONCEPT ANALYSIS OF PAROXYSMAL SYMPATHETIC
HYPERACTIVITY AFTER SEVERE TRAUMATIC BRAIN INJURY
Overview
Paroxysmal Sympathetic Hyperactivity (PSH) is a phenomenon that is
seen following a variety of neurological insults. In particular, it is well described
following severe traumatic brain injury (TBI) (Baguley, 2008a; Baguley et al.,
2006; Baguley, Nott et al., 2009; Boeve et al., 1998a; Lv et al., 2011). PSH
consists of paroxysmal sympathetic discharges (Baguley, 2008b; Lemke, 2007)
thought to result from an imbalance in afferent and efferent systems which alter
the normal excitatory:inhibitory ratio (EIR) of the autonomic nervous system
(Baguley, 2008b). This results in a constellation of symptoms, including
tachycardia, hypertension, diaphoresis, hyperthermia and spontaneous
posturing. These paroxysms occur at intervals throughout the day, usually in
response to a stimulus or “trigger”. Once a stimuli manifests, the patient with
PSH exhibits the multiple symptoms of physiologic distress. During these
episodes, additional nursing care may be hampered in an effort to avoid
additional problems such as hypertensive crisis, improper positioning or a
prolonged hyperadrenergic state.
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Background
PSH has been reported in up to 33% of patients with severe TBI (Hinson
& Sheth, 2012) and is thought to increase morbidity and mortality related to TBI
(Fernandez-Ortega et al., 2006). To date, the vast majority of literature pertaining
to PSH is found in the medical literature with attention paid to hypothesis of
cause and pharmacologic management. However, little is stated regarding the
role of the nurse in the recognition and management of PSH. Clarification of this
concept will aid the nurse in identifying the phenomena and guide interventions
to improve the symptomatology and thereby outcomes.
Rogers (2000) evolutionary method of concept analysis was used to
evaluate the concept of PSH. This eight-step process allows for in depth
investigation of the term, with interval development of model cases used to
describe the phenomena of PSH, formerly known as sympathetic storming. The
concept of PSH can also be considered in the theoretical context: the theory of
unpleasant symptoms (Lenz, Pugh, Milligan, Gift, & Suppe, 1997; Lenz, Suppe,
Gift, Pugh, & Milligan, 1995). This nursing theory was initially used to discuss the
multiple symptoms (fatigue and dyspnea) in post-partum and COPD patients
(Lenz et al., 1995). More recently, it has been used to investigate multiple
symptoms in Alzheimer’s disease (Hutchinson & Wilson, 1998) and multiple
sclerosis (Motl, 2014). In short, this middle range theory can be used to
investigate the inter-relationships of multiple related symptoms as they exist in a
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single disease process, and subsequently their effect on functional and cognitive
performance (Lenz, Gift, Pugh & Milligan, 2012).
Surrogate Terms
PSH has been discussed in the literature under a variety of terms. Early in
the recognition of this phenomenon, the term diencephalic seizure was used.
However, later investigations failed to demonstrate seizure activity on
electroenecephalography so this term became obsolete (Boeve et al., 1998a;
Lemke, 2007). It later became known as dysautonomia, autonomic storming,
sympathetic storming, and autonomic dysreflexia or hyper-reflexia. The
International Brain Injury Association recently convened a consensus workgroup
to clarify the nomenclature and diagnostic criteria for this entity. The proposed
term is paroxysmal sympathetic hyperactivity (Baguley, 2013) although the term
sympathetic storming maintains a clinical stronghold.
Methods
A literature review was conducted using MEDLINE and CINAHL. No time
limitations were specified. A search for the widely used clinical term of
sympathetic storming combined with severe traumatic brain injury was
performed. This search yielded only four articles. These articles and their
corresponding reference lists were reviewed and additional search terms of
diencephalic seizures, dysautonomia, autonomic storming, autonomic
hyporeflexia, paroxysmal sympathetic hyperactivity, and autonomic hyper-reflexia
were identified. These terms were also combined with traumatic brain injury to
eliminate other similar autonomic conditions associated with congenital birth
14

defects, spinal cord injury, and other non-traumatic brain pathology. PSH and its
surrogates were also combined with the term unpleasant symptoms, yielding no
further results. The website for the Brain Injury Association of America was also
queried as they were known to have a workgroup focusing on autonomic
dysfunction. Additional query of the World Wide Web failed to produce any
articles of sufficient quality to warrant inclusion. In sum, twenty articles specific to
the concept of PSH were included.
References, Antecedents, and Consequences
PSH, frequently called sympathetic storming, can be likened in some ways
to the more well-known phenomenon, a thunderstorm. The thunderstorm occurs
when in the presence of sufficient atmospheric moisture; warm air and cooler air
collide, thus creating an unstable environment. Subsequently, the “symptoms,”
thunder, lightning, wind gusts, and rain occur. In some cases, thunderstorms
continue to move through a geographic area until the stimulus, usually water
vapor has diminished (Anonymous, 2012). Like a thunderstorm, these
sympathetic storms or paroxysms begin rapidly with minimal stimuli, yielding
multiple symptoms while disrupting normal homeostasis of the body. Once the
trigger is removed or afferent input blunted, the “storm” can then dissipate.
Acquired brain injury, specifically severe traumatic brain injury (TBI), is an
absolute antecedent for the development of PSH. The presence of diffuse axonal
injury on imaging studies has previously been associated with PSH (Baguley et
al., 2004; Boeve et al., 1998a). Initial symptoms of PSH are frequently blunted by
the use of opiates and sedatives in the intensive care unit. As these medications,
15

are weaned, symptoms may be become prevalent. Baguley suggests that PSH is
present if 5 or more of the following symptoms are present without other
identifiable causes: hyperthermia, tachycardia, tachypnea, dystonia,
hypertension, posturing and diaphoresis (Baguley et al., 2014). No further
attributes were identified).
If the symptoms are unrecognized or misattributed to other conditions by
the nurse or medical team, a delay in appropriate treatment may result. A lag in
condition specific treatment for these storming episodes can result in dysfunction
of multiple organ systems. These consequences can result in permanent organ
injury (i.e. myocardial infarction), prolonged intensive care unit length of stay,
increased health care costs, and delayed recovery (Hinson & Sheth, 2012).
Model Cases
Model Case
SM is a 24-year-old male who was involved in a motor vehicle collision.
He sustained a severe traumatic brain injury with an initial Glasgow Coma Score
of 5. He required mechanical ventilation and intracranial pressure management
for 10 days following his injury. Since weaning from the ventilator and sedation,
he has developed periods of labile vital signs and other evidence of autonomic
dysfunction. During these episodes, his heart rate (HR) is 150 beats per minute,
blood pressure (BP) 170/92 mmHg, respiratory rate (RR) 38 breaths per minute,
and he requires frequent linen changes due to profuse diaphoresis. At times, he
exhibits extensor tone, which makes positioning difficult.
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Contrary Case
TS is an 18 year old female who has been hospitalized for 24 hours
following a penetrating brain injury. On admission, she had no corneal reflexes
and fixed and dilated pupils. Her Glasgow Coma Score was 3. Most recent vital
signs reveal HR 170 beats per minute, BP 200/98 mmHg, RR 12 breaths per
minute per ventilator and intracranial pressure (ICP) 70 cm/H20. She has no
motor response to noxious stimuli and no spontaneous respirations. While this
patient is in a hyperadrenergic state, this scenario is more consistent with
cerebral herniation syndrome than paroxysmal sympathetic hyperactivity.
Interdisciplinary and Temporal Comparisons
Nursing surveillance (Kelly, 2011) is conducted throughout the critical
phases of TBI recovery. It is through this surveillance, observing abnormal vital
signs and physical findings and interpretation of their meaning that the diagnosis
of PSH is suspected. Communication of these findings to the medical staff is
pivotal in confirming PSH as many of the symptoms (i.e. posturing, diaphoresis)
are not readily ascertained from scanning the nursing notes or vital signs in the
medical record. Even if identified, it is difficult to reconstruct the PSH or
“storming” episode. Furthermore, the direct communication between nurses and
medical staff remain critical with the increasing number of patient handoffs due to
work hour restrictions, and transfer of care from specialists in neurological care to
general practitioners who are less familiar with the complications associated with
TBI. Another method of relaying the variability in the patient condition involves
interdisciplinary team rounds. This method of communication has been shown to
17

improve outcomes in high-risk populations (Kauh, Polak, Hazelett, Hua, & Allen,
2005).
Implications
Early identification and treatment of PSH is critical to facilitate recovery
from traumatic brain injury and avoid permanent organ dysfunction. Expensive
diagnostic testing is rarely warranted. Instead, the observational and analytical
skills employed by most ICU nurses are most useful. In addition to
communication of findings in order to facilitate diagnosis and treatment, nursing
surveillance also affords the opportunity to identify and therefore, potentially
mitigate triggers (Figure 2). These triggers or activities that may stimulate the
sympathetic activity vary by patient and may be divided into external and internal
stimuli. External triggers are commonly thought to be necessary nursing activities
such as suctioning or positioning, caressing by the family, or excessive auditory
stimulation (i.e. radio, monitor alarms) (Lemke, 2003; 2007). However, even with
astute observation, a trigger is not always immediately identified and internal
stimuli such as pain, constipation, or obstructed urinary catheters should be
considered. A final contribution of nursing involves family and caregiver teaching.
In this role, the nurse explains the concept of sympathetic storming or PSH, its
causes, and treatment, thereby aiding the family member to better cope with the
paroxysms (or “storms”) that can be very frightening or chaotic to watch.
Early initiation of symptom specific therapy, although beyond the scope of
this paper, is thought to decrease complication rates, ICU length of stay, and
facilitate recovery (Hinson & Sheth, 2012). Understanding both the cause and
18

complexity of these PSH events, will lead to improved diagnosis and therapeutic
interventions.
Conclusion
PSH should be considered when patients emerging from coma exhibit
multiple, concurrent symptoms of sympathetic over-activity: hyperthermia,
posturing, dystonia, tachycardia, tachypnea, diaphoresis, or hypertension.
Nurses play a pivotal role in identifying the condition of PSH, observing and
mitigating the triggers which precipitate the event, communicating patient needs
to the interdisciplinary team, and finally, educating the family/caregivers. Ongoing
research should include efforts to develop scales to document the frequency and
severity of these paroxysmal episodes, as well as determine the impact of
aggressive nursing care on the outcomes of this phenomenon.
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CHAPTER IV
THE IMPACT OF PAROXYSMAL SYMPATHETIC HYPERACTIVITY
FOLLOWING TRAUMATIC BRAIN INJURY ON INTENSIVE CARE UNIT
LENGTHOF STAY AND DISCHARGE DISPOSITION

Overview
The purpose of this study was to determine the incidence of Paroxysmal
Sympathetic Hyperactivity (PSH) in an American level 1 trauma center, and
examined the differences between patients with severe TBI and those who
develop PSH in terms of intensive care unit length of stay (ICULOS) and
discharge disposition. Additionally, the study identified predictors of ICULOS in
the patients with PSH.
PSH is a complication affecting a subset of patients with severe traumatic
brain injury. It is associated with increased morbidity, longer lengths of stay, and
delayed recovery (Perkes, Baguley, Nott, & Menon, 2010). The most prevalent
signs and symptoms of PSH include unprovoked tachycardia, tachypnea,
hypertension, dystonia, and diaphoresis (Lemke, 2007). There has also been an
association with prolonged pyrexia (Rabenstein, 2007). If untreated, PSH can
lead to impaired cerebral perfusion, myocardial damage, dehydration,
malnourishment, and contractures (Lemke, 2007).
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Background
Traumatic brain injury (TBI) is a public health crisis with over 1 million new
cases in the United States annually (Corrigan, Selassie, & Orman, 2010; CDC,
2010). Approximately ten percent of these injuries result in severe TBI with
prolonged periods of coma and post-traumatic amnesia (Bruns & Hauser, 2003).
The impaired neurologic function associated with severe TBI requires prolonged
hospitalizations, invasive monitoring and intensive neuro-rehabilitation and in
many cases, can result in life-long disability. As a result, the small percentage of
patients with severe TBI, utilize the biggest proportion of TBI resources and
healthcare dollars (CDC, 2010; McIlvoy, 2001). An even smaller subset of severe
TBI can develop paroxysmal sympathetic hyperactivity (PSH) (Baguley, 2008a;
Baguley et al., 2009; Hinson & Sheth, 2012). This condition is characterized by
periods of excessive activation of the sympathetic nervous system, resulting in
intermittent episodes of hypertension, tachycardia, tachypnea, diaphoresis, and
abnormal motor responses (Fernandez-Ortega et al., 2012; Gao, Pollock, &
Hinson, 2014; Hinson & Sheth, 2012; Lemke, 2003; 2007). Known to mostly
affect younger patients and those with diffuse rather than localized brain injury,
PSH symptoms can last for days to years (Baguley et al., 2006; FernandezOrtega et al., 2012; Lv et al., 2011).
Because patients with PSH exhibit periods of physiologic distress, it is
postulated that they have longer stays in the intensive care unit (ICULOS) and
are more likely than other TBI patients to require ongoing medical care and
increased resource utilization. A retrospective study was performed to determine
21

the differences in ICULOS and discharge dispositions from acute care. The
physiologic parameters of heart rate (HR), systolic blood pressure (SBP),
temperature (T), respiratory rate (RR), and free water requirements at specific
time points during the hospital stay were explored to determine which factor most
influenced ICULOS.
Methods
A retrospective design of medical record review was used. A multivariate
analysis of variance (MANOVA) was performed to determine group differences in
the following parameters: heart rate (HR), systolic blood pressure (SBP),
temperature (T), respiratory rate (RR), intracranial pressure (ICP) and free water
requirements. In addition to age and GCS, physiologic factors showing statistical
significance between groups were entered as predictors in a multiple regression
model to determine factors most predictive of ICULOS, thereby facilitating a
clinically relevant starting point for treatment of PSH.
Measures
Variables associated with PSH were identified from previous literature.
Physiologic parameters were abstracted from the vital sign flow sheet record in
the electronic medical record. The highest and lowest recorded values in a 24
hour period where captured for each parameter. The first variable, HR was
measured in beats per minute as auto-recorded by Hewlett-Packard telemetry.
SBP, measured in mm Hg was captured preferentially from arterial line
monitoring, In the absence of invasive SBP monitoring, values were captured
from automatic non-invasive blood pressure cuff monitoring using Hewlett22

Packard monitoring devices. Temperature, measured in degrees Fahrenheit was
captured from the vital sign registry. Location of temperature measurement was
not routinely identified. When a ventriculostomy was in place, ICP values in cm of
water were obtained using strain-gauge catheters with Hewlett Packard
monitoring. When measured by a parenchymal bolt, ICP was obtained from
Integra® Camino® technology. Free water requirements were measured as the
amount of water in milliliters required in a 24 -hour period to maintain normal
serum sodium, blood urea nitrogen, and serum creatinine values. This
information was abstracted from the medication administration record.
Length of stay was calculated in days. ICULOS was calculated by
subtracting the day transferred out of ICU from the day of admission. Hospital
LOS was calculated by subtracting the day of discharge from the day of
admission. Discharge disposition, i.e. the level of care the patient was
transferring to following acute hospitalization, was identified from the nursing
narrative and care coordination notes. The GCS was identified from the
neurosurgery consultation and nursing notes. The Injury Severity Score (ISS)
incorporates injury to different body parts to a summed score representing the
overall injury severity. Higher ISS scores are associated with higher morbidity
and mortality. The Abbreviated Injury Score- head (AIS-head) was captured as it
reflects the injury severity specific to the head. The ISS ranges from 0-75 and
AIS- head from 1-6; higher scores on both scales are indicative of more severe
injury. The ISS and AIS-head were calculated at hospital discharge by the
trauma registrars and were obtained directly from the Trauma Institute database.
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Procedures
Following approval of the local institutional review board (IRB), the trauma
database was queried. A list (N= 620) was generated that included all trauma
patients treated at a level 1 trauma center from the years 2010- 2015 presenting
with evidence of a head injury and admission Glasgow Coma Score ≤ 8,
indicating coma or severe TBI. The principal investigator reviewed each chart for
inclusion/exclusion criteria. This yielded 196 cases meeting the inclusion criteria:
severe TBI as defined by Glasgow Coma Score (GCS 4-8) and age greater than
or equal to 16 at time of hospital admission. Cases were excluded if the postresuscitation GCS was 3 or > 8, there was concomitant spinal cord injury,
presence of bilateral non-reactive pupils, orders for comfort measures only within
the first 5 days of hospitalization, or there was the absence of a mechanical
traumatic mechanism. A large number of cases were excluded as the admission
GCS was influenced by the use of neuromuscular blocking agents or high dose
sedatives (Table 2). Included cases were dichotomized into two groups by the
principal investigator: those with documented PSH or strong suspicion based on
chart review (PSH group, n = 45) and those without evidence of PSH (TBI group,
n = 151). Data were extracted from the medical records on patient hospital days
1, 7, 14, 20 and the day of discharge.

Data Analysis
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Analysis was performed using SPSS v 22. Student’s t-test was used to
assess normally distributed data for differences in age, admission/discharge
GCS, and overall ISS. Similarly, ANOVA was used to evaluate for differences in
mechanism of injury and AIS-H and discharge disposition. Given appropriate
correlations of the physiologic parameters, a MANOVA was used to assess for
any between group differences. Statistically significant parameters were included
in the multiple regression analysis using hierarchal entry to identify which factors
were most likely to predict ICULOS. Not all patients required hospitalization
through day 20. Therefore, every patient underwent analysis of physiologic
parameters at days one and seven, but those with early discharges were
removed from further analysis after their discharge date to avoid the appearance
of excessive missing data.
Results
Admission Characteristics
There was no difference in admission GCS between groups (TBI versus
PSH); the mean of both groups was 6 (p=0.143). Age at time of injury was
significantly different (p =.002) between groups (Table 3). Patients exhibiting
PSH were younger (mean age 28 years, SD 10.7) compared to the TBI group
(mean age 38 years, SD 15.9). Patients with PSH had significantly worse overall
ISS (mean 32.9, SD 8.63) compared to the TBI group (mean 29.2, SD 10, p=
0.012) although the severity of injury specific to the head was no different (AIS-h
p=0.114). High velocity injury from motor vehicle collision was the predominant
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mechanism of injury in both groups (TBI- 64% versus PSH 82%, p = 0.079)
(Figure 3).
Patient Characteristics During Hospital Stay
Day 7 analyses included all 196 patients. Patients were dichotomized to
the TBI group (n = 151) and PSH group (n= 45) based on the presence or
absence of PSH symptoms. Subject attrition due to early discharge resulted in
181 patients included in the day 14 analyses, and 137 patients in the day 20
analyses.
Monitoring of intracranial pressure (ICP) was done at the discretion of the
attending neurosurgeon. As a result, 81 patients had ICP monitoring on day 1,
with 87 patients monitored on day 7 and only 33 patients required ongoing
monitoring on day 14. Of those with ICP availability, there was a minor clinical,
but statistically significant difference in mean ICPs between groups on day 1 but
not on subsequent days (p=.001 with TBI mean 16.11 cm H20, SD 7.82 and PSH
mean 22.83, SD 7.99).
The amount of free water (mL) administered in order to maintain a normal
sodium level was recorded as a marker of hydration status. This was found to
only be significant on the day of discharge. Patients with PSH required a mean of
829 mL (SD 789mL) while patients without PSH required only 366 mL (SD 479
mL). Many of the patients in the standard TBI group (n=72), required no
supplemental free water at hospital discharge.
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Prior to analysis, statistical assumptions were assessed. Independence
was confirmed as patients were assigned to only one group (TBI or PSH).
Levene’s tests were non-significant indicating similar variances between groups.
Evaluations of mechanism of injury and discharge dispositions initially failed to
show a normal distribution, therefore, groups were collapsed to improve
normality.
Pearson correlation coefficients (r) indicated small to moderate
correlations between the physiologic factors with absolute values of r ranging
from .05 to .521. Additional testing for multicollinearity demonstrated a variance
inflation factor (VIF) < 2 and tolerance > .3 for all parameters. Subsequently, a
between subjects multivariate analysis of variance (MANOVA) was conducted to
evaluate the physiologic parameters of heart rate (HR), systolic blood pressure
(SBP), respiratory rate (RR), and temperature (T) in patients with and without
PSH. Parameters included were the daily minimum value, daily maximum value,
and frequency that the parameter was recorded outside of the pre-established
normative range during the 24-hour collection period. Day one data was initially
collected but not analyzed for two reasons. First, the literature clearly states that
PSH is not present at the time of injury (day 1), and secondly, the protocol did not
include a mechanism to control for the physiologic abnormalities associated with
resuscitation and in some cases, hypovolemic shock. The results from days 7,
14, and 20 are presented in Tables 4, 5, and 6 respectively. Day 7 reflected
between group differences in maximal HR (p< .001), HR frequency (p = .004)
and maximal RR (p= .008). Post hoc testing demonstrated marginal effect sizes
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with Odds Ratio (OR) of 1 and confidence intervals (CI) centered at 1 for all three
parameters, suggesting that all though there was statistical significance between
groups the difference had no bearing on the overall outcomes of LOS or
discharge disposition. Day 14 analysis yielded only significant findings of
maximal HR (p <.001, OR 1.006, CI 1.022-1.010) and maximal RR (p = .038, OR
1.027, CI 1.017 -1.038). By day 20, no significant differences in any parameters
were noted between groups.
The final aim of this research was to determine which previously identified
factors significant predicted ICULOS. To address this aim, ICULOS was
regressed on the factors HR maximum day 7, HR frequency day 7, HR maximum
day 14, RR maximum day 7, and HR frequency on day of discharge, in a
hierarchical fashion. Factors were entered into the regression equation based on
the degree of statistical significance from the previous MANOVA. ISS and age
were also significant on initial analysis and were subsequently added to the final
models. Maximum HR day 7 was entered in the first block, yielding an
insignificant result. Maximum HR day 14 was added next, explaining 5.6% of the
variability in ICULOS (R2 = .056, F1,174 = 10.247, p = 0.002). HR frequency at day
7 was then added without noticeable contribution. Maximum RR at day 7 was
then added producing R2 =.124 with R2 change of .068 (F1, 172 = 13.366, p <
.001). HR frequency at discharge, RR minimum at discharge, age, and ISS were
subsequently added in additional blocks without appreciable explanation of
variability or statistical significance. Although model 4, which incorporated HR
maximum for days 7 and 14, HR frequency at day 7 and RR maximum at day 7
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accounted for only 12.4% of the variability in ICULOS, it was believed to be most
reliable predictor of ICULOS.
Discharge Characteristics
All patients had day of discharge comparisons although the length of stay
varied considerably (range 14-143 days). Both ICU and hospital lengths of stay
were similar between groups (p= .245 and p= .1 respectively). Median ICULOS
was 18.1 days (SD 10.6 days) in the TBI group and 19.1 days (SD 9.84 days) for
the PSH group while hospital length of stay (HOSPLOS) was 28.4 days (SD 19.3
days) in the TBI group and 30.2 days (SD 15 days) in the PSH group (Table 7).
Discharge GCS was significantly lower in the PSH group (p=.002). Mean
GCS in the PSH group was 10.8 (SD 2.55) compared to the TBI group mean of
12.1 (SD 2.93).
When evaluating discharge dispositions, an ANOVA was used with the
following discharge disposition groups:
1. Home or assisted living
2. Acute rehabilitation
3. Sub-acute rehabilitation, coma emergence programs or skilled

nursing facility
4. Other or not specified disposition (includes long-term acute care,

other acute care hospitals).
The F test was statistically significant (p= .009) suggesting that patients with PSH
were less likely to be discharged to home (2.2%) compared 8.6 % in the TBI
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group, or acute rehabilitation settings (42.2% PSH group versus 69.9% TBI
group).
Post hoc testing showed a small to moderate effect between the groups
with home versus acute rehabilitation (Odds Ratio (OR) 1.473 and 95%
confidence interval (CI) 0.155-13.99), sub-acute rehabilitation versus acute
rehabilitation (OR 0.112, 95% CI 0.036-0.353) and other versus acute
rehabilitation (OR 0.160, 95% CI 0.022-1.143). Essentially, patients with an
expected TBI course were 1.5 times more likely to be discharged to high level
neuro-rehabilitation than those with PSH and were substantially less likely to
require long-term skilled nursing or sub-acute rehabilitation.
Discussion
Findings from this study and others, suggest that despite appropriate TBI
treatment, up to one third of the severe TBI population will develop PSH; a
complication that increases hospital length of stay, morbidity, and long-term
disability (Hendricks, Heeren, & Vos, 2010; Hinson & Sheth, 2012; Lv et al.,
2010; & Perkes et al., 2010). Data from this study suggests that multiple
episodes of tachycardia, present on post-injury days 7 and 14, are associated
with the development of PSH. Other factors, including temperature, blood
pressure, and respiratory rate appear to be less indicative of PSH.
Upon discharge from acute care, disposition varies mostly based on the
patients level of arousal, although social factors or health system factors may
also influence discharge disposition. For example, Argentina lacks formal neurorehabilitation programs; therefore, over 60% of patients with TBI are discharged
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to homecare (Rondina et al., 2005). Acute rehabilitation typically requires that
patients actively participate in three or more hours of therapy a day and is the
preferred discharge locale for patients with significant TBI. In the Unites States,
over fifty percent of patients with severe TBI are discharged to rehabilitation
(Bauer, McGwin, Melton, George, & Markert, 2011; Livingston, Tripp, Biggs, &
Lavery, 2009). Transfer to sub-acute rehabilitation or skilled nursing facilities is
largely associated with lower Glasgow Coma Score or other socioeconomic
factors, specifically, government funded healthcare (Chan et al., 2001; Cuthbert
et al., 2011; Hoffman et al., 2012). Bauer et al., (2011) reported that 25% of his
sample were discharged to sub-acute rehabilitation with only 13% discharged to
home. Others report rehabilitation rates as high as 89%, although there was no
distinction between acute and sub-acute rehabilitation (McIlvoy, 2001; Vitaz et
al., 2001). A cost benefit analysis suggests that aggressive care of the TBI
patient, including acute rehabilitation is “significantly less costly than routine care”
over time (Whitmore et al., 2012).
While this study indicates that PSH has no effect on short-term outcomes,
such as ICULOS or HOSPLOS, the findings suggest that patients with PSH are
less likely to qualify for acute rehabilitation upon hospital discharge. Because
patients with PSH are discharged with lower levels of neurologic function, it can
be inferred that patients with PSH have prolonged resource needs at increased
costs and are less likely to receive specialty neurotrauma rehabilitation, which
may further delay recovery and community re-entry. It remains unclear what
factors are related to delayed responsiveness (lower GCS) in patients with PSH
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and if any treatment modalities to improve early wakefulness (higher GCS) might
lead to earlier brain injury rehabilitation.
Contrary to expected findings, there were minimal differences in virtually
all physiologic parameters. While this may be related to early treatment of PSH, it
may also be affected by the small sample size. Given the hemodynamic
similarities between groups, it is not surprising that that no difference in ICULOS
was identified. Except for free water requirements, no other differences in
physiologic parameters were identified on the day of discharge. It was anticipated
that parameters on day of discharge would be non-significant as a labile
hemodynamic status is a contraindication for discharge.
Limitations
This study has several limitations. The sampling bias associated with use
of a convenience sample limits the generalizability of these findings to other
populations. Future studies would benefit from multi-center sampling.
The retrospective nature of the study limited the usefulness of the recently
standardized definition of PSH that requires patients to exhibit five or more of the
following symptoms without provocation: hyperthermia, dystonia, tachypnea,
diaphoresis, hypertension, and tachycardia. Patients were included in the PSH
group if they carried a diagnosis of PSH or had only 3 or more associated
symptoms occurring 3 or more times in a 24 hour period since it was not possible
to readily identify symptoms such as dystonia or diaphoresis from the existing
documentation. Therefore, patients may have been included in the PSH group
without meeting all diagnostic criteria.
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Retrospective studies are traditionally at high risk for missing data. In an
effort to mitigate this, variables were collected across a 24-hour period instead of
specified hours, thus ensuring capture of minimum and maximum values for each
physiologic parameter. Facility policy dictates hourly vital signs with the exception
of temperatures (monitored every 4 hours) in acute trauma patients; as a result,
temperatures were the only variable with missing data. This condition was
isolated to patients who were admitted after 8 pm.
The scope of this study did not allow for evaluation of treatment effects on
PSH. While it appears that patients with PSH exhibit slower awakening than their
counterparts as evidenced by the lower discharge GCS, it is not clear if this is
related directly to the development of PSH or other dynamic elements. Other
factors that may contribute to ongoing poor neurologic function include cortical
and subcortical pathologies, delayed initiation of neuro-stimulants because of
adrenergic hyperactivity, hormonal imbalances or other unidentified conditions.
Finally, during the years of interest, the principal investigator was actively
engaged in the critical care management of patients with severe TBI and
pursuing research interests in PSH. As a result, patients with PSH were
diagnosed within the first two weeks of injury and symptoms were treated
accordingly. The lack of statistical significance between groups may be a
reflection of the aggressive identification and treatment of PSH in the affected
group.
Conclusion
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Despite the study’s limitations, findings indicate it is reasonable to utilize
routine screening mechanisms for PSH in high-risk patients with severe TBI,
particularly younger patients with early evidence of unprovoked tachycardia.
Lower discharge GCS and discharge to facilities other than acute rehabilitation,
suggest that patients with PSH have a delayed recovery. Additional studies are
needed to determine if coma stimulation-type interventions improve the
wakefulness of patients with PSH, therefore allowing earlier attempts at neurorehabilitation. Additional studies evaluating the efficacy of different treatment
modalities are necessary in order to establish an evidence-based treatment
algorithm for PSH. Lastly, future projects should focus on determining if
differences in long-term recovery and functional status exist or if the natural
history of PSH stabilizes, allowing equalization of outcomes in the long-term.
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Table 2
Explanation of Included and Excluded TBI Cases
Total Cases With Admit

Reason

N = 620

GCS < 8 From Registry

Included/Excluded

2010-2015
Excluded

N=424
Death

N=113

Mild TBI (GCS 13-15)

N=69

Moderate TBI (GCS 9-

N=203

12)

Included

No TBI (anoxia, stroke)

N=39

Age<16

N=2

Transfer within 1 week

N=1

Post-resuscitation GCS

N=196

4-8

GCS- Glasgow Coma Score
TBI- Traumatic brain injury
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Table 3
Admission Characteristics of Patients with Severe Traumatic Brain Injury
Admitted to a Level 1 Trauma Center Between 2010-2015 (N=196).
Variable

TBI (n=151)

PSH (n=45)

Significance

AGE Mean (SD)

37.9 (15.9)

27.7 (10.7)

p<.001*

Median

38

24

GCS Mean (SD)

6.38 (1.16)

6.29 (1.16)

Median

7

6

ISS Mean (SD)

29.2 (10)

32.9 (8.63)

Median

29

33.5

3

27

4

4

57

13

5

67

27

p=0.143

p=0.01*

AIS Head
p=0.114

GCS= Glasgow Coma Score
ISS= Injury Severity Score
AIS-Head= Abbreviated Injury Severity-Head (1 & 2 excluded as minor, 6 as
fatal)
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Table 4
Hospital Characteristics of Patients with Severe TBI on Day 7 (N=196)
Variable

TBI Group

PSH Group

Significance

(N=151)

(N= 45)

Min Mean (SD)

74.1 (14.8)

74.6 (14.4)

p= 0.774

Max Mean (SD)

107 (17.6)

118 (18.5)

p=<0.001*

Frequency (SD)

1.26 (3.73)

1.47 (2.94)

p= 0.003*

Min (SD)

113 (13.4)

110 (14.6)

p=0.148

Max (SD)

159 (17.4)

160 (16.1)

p= 0.797

Frequency (SD)

7.21 (6.35)

6.93 (2.94)

p= 0.807

Min (SD)

98.7 (0.97)

98.8 (0.97)

p=0.922

Max (SD)

101 (1.2)

101 (1.2)

p=0.375

Frequency (SD)

2.85 (3.08)

3.92 (3.08)

p=0.341

Min (SD)

15.9 (4.67)

16.8 (3.73)

p=0.190

Max (SD)

25.7 (5.93)

28.7 (7.17)

p=0.008*

Frequency (SD)

8.35 (8.01)

10.7 (8.51)

p=0.077

HR beats per min

SBP mm Hg

Temp degrees F

RR breath/minute

TBI- Traumatic brain injury
PSH- Paroxysmal sympathetic hyperactivity
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HR- Heart rate in beats per minute
SBP- Systolic blood pressure
Temp- Temperature in degrees Fahrenheit
RR- Respiratory rate in breaths per minute
SD- standard deviation
Min-Minimum value
Max-Maximum value
Frequency- Number of times above pre-defined normal value
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Table 5
Characteristics of Patients with Severe Traumatic brain Injury on Hospital Day 14
(N= 181)
Variable

TBI Group

PSH Group

Significance

(n=137)

(n=44)

Min (SD)

80.7 (15.9)

83.7 (16.0)

p=0.295

Max (SD)

111 (18.7)

122 (14.8)

p<0.001

Frequency (SD)

1.33 (3.84)

2.32 (4.00)

p=0.054

Min (SD)

110 (13.9)

109 (13.2)

p=0.276

Max (SD)

148 (18.3)

152 (17.7)

p=0.130

Frequency (SD)

3.82 (5.42)

4.52 (5.54)

p=0.238

Min (SD)

98.2 (1.20)

98.4 (0.666)

p=0.602

Max (SD)

99.3 (7.99)

100 (1.11)

p=0.289

Frequency (SD)

1.35 (2.60)

1.39 (2.31)

p=0.597

Min (SD)

17.5 (3.95)

17.2 (3.87)

p=0.975

Max (SD)

26.8 (6.70)

28.3 (6.67)

p=0.147

Freq (SD)

8.33 (8.20)

10.1 (8.56)

p=0.279

192 (351)

229 (436)

P=0.850

HR-beats per min

SBP mm HG

Temp in F

RR breath/minute

Free Water (mL)
Mean (SD)
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SD- Standard deviation
TBI- Traumatic brain injury
PSH- Paroxysmal sympathetic hyperactivity
Temp- Temperature
Min- Minimum value
Max- Maximum value
Frequency- Number of times above predefined normal value
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Table 6
Characteristics of Patients with Severe Traumatic Brain Injury on Hospital Day 20
(N= 137)
Variable

TBI Group

PSH Group

Significance

(n=101)

(n=36)

Min (SD)

82.7 (15.4)

81.8 (14.4)

p=0.940

Max (SD)

108 (17.4)

114 (17.3)

p=0.074

Frequency (SD)

0.95 (2.87)

1.39 (2.77)

p=0.126

Min (SD)

111 (14.1)

105 (12.0)

p=0.053

Max (SD)

141 (18.1)

144 (18.0)

p=0.468

Frequency (SD)

1.86 (3.53)

1.97 (3.97)

p=0.715

Min (SD)

97.8 (0.92)

98.0 (0.76)

p=0.177

Max (SD)

100 (10.2)

99.6 (1.13)

p=0.373

Frequency (SD)

0.69 (2.15)

0.42 (0.77)

p=0.7337

Min (SD)

17.2 (3.61)

16.1 (3.10)

p=0.059

Max (SD)

23.4 (5.63)

24.7 (7.60)

p=0.771

Frequency (SD)

4.44 (7.10)

5.64 (7.82)

p=0.613

296 (463)

391 (573)

p=0.434

HR beats /min

SBP mm Hg

Temp deg F

RR breaths/min

Free Water (mL)
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TBI- Traumatic brain injury
PSH- Paroxysmal sympathetic hyperactivity
HR beat/min- Heart rate in beats per minute
SBP- Systolic blood pressure
Temp deg F- Temperature in degrees Fahrenheit
RR- Respiratory rate in breaths per minute
SD- Standard deviation
Frequency- Number of times above predetermined normal value

42

Table 7
Discharge Characteristics of Patients with Expected TBI Recovery and Those
with PSH (N= 196).
Variable

TBI (n= 151)

PSH (n= 45)

Significance

Mean(SD)

12.1 (2.55)

10.8 (2.93)

p=0.002

Median

14.0

10.5

Mean (SD) day

18.1 (10.6)

19.1 (9.84)

Median day

16.0

17.0

Range in days

5-83

7-65

Mean (SD) day

28.4 (19.3)

30.2 (15)

Median day

23.0

24.0

Acute %

60.9

42.2

Home/AL %

8.6

2.2

SAR/SNF/Emerge %

23.8

48.9

Other %

6.6

6.7

Discharge GCS

ICULOS
p=0.245

HOSPLOS
p=0.100

Discharge Dispo

TBI- Traumatic brain injury
PSH- Paroxysmal sympathetic hyperactivity
GCS- Glasgow Coma Score
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p= 0.009

ICULOS- Intensive Care Unit length of stay
HOSPLOS- Hospital Length of Stay
Discharge Dispo- Discharge disposition
Acute-Acute rehabilitation
AL-Assisted living
SAR- Subacute rehabilitation
SNF- Skilled nursing facility
Emerge- Coma emergence program
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Figure 3
Mechanism of injury for traumatic brain injury, years 2010-2015TBI versus PSH
groups (p=.079)

MVC includes: All-terrain vehicle, motorcycle, motor vehicle, and moped crashes
Ped v Auto- includes any pedestrian struck my motorized vehicle
Other includes: Plane accident, bicycle accident, found down, assault, and
gunshot wound.
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CHAPTER V
SUMMMARY AND CONCLUSIONS

Paroxysmal sympathetic hyperactivity is a complication that follows TBI in
a small percent of patients in a coma (Fernandez-Ortega et al., 2012). Although
cases of PSH were identified over 60 years ago, formal diagnostic criteria and
nomenclature have only been established within the last five years (Baguley et
al., 2014). To date, most of the research in this area has emerged from a single
group in Australia. Their findings indicate that patients who develop PSH are at
risk for increased morbidity, prolonged ICULOS, and delayed recovery
(Fernandez-Ortega et al., 2012; Baguley, 2008a; Penfield, 1929; Baguley et al.,
2006; Baguley et al., 1999).
Consistent with prior research, this study suggests that younger patients
with severe TBI are most at risk for developing PSH. The presence of diffuse
axonal injury on imaging studies has been associated with PSH (Hinson & Sheth,
2012; Lv et al., 2011). However, other clinically relevant injury related factors
(AIS-head, ICP, admission GCS) do not have an obvious linkage to the
development of PSH.
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Early and persistent episodes of non-specific tachycardia appear to be
the most sensitive indicator for PSH although other factors such as early
tachypnea and late pyrexia after TBI may also indicate the presence of PSH. As
most of the patients in this study were diagnosed with PSH early in their hospital
course and had ICULOS similar to their TBI counterparts, it is possible that early
PSH intervention may prevent prolonged ICULOS and thereby associated
complications. Comparative studies looking the effects of early versus delayed
treatment of PSH may offer insight into the differences in outcomes from various
studies.
Despite similar admission characteristics, ICULOS, and HOSPLOS,
patients with PSH appear to have slower awakening from coma as evidenced by
lower discharge GCS. Poor neurologic function at discharge likely influences
discharge disposition. Patients with PSH are less likely to be discharged to acute
neurorehabilitation than their TBI counterparts who follow an expected TBI
recovery trajectory.
Much is left to learn about the complex condition of PSH. Future research
priorities should include:
• Creation and validation of a PSH screening tool
• Development of evidence-based treatment protocols
• Establishment of the natural history of PSH
• Determine the long-term functional outcomes of patients with PSH
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Due to the low incidence of PSH, sample size limitations pose a significant
problem in powering single site studies. For this reason, multi-center studies
should be considered.
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